Φορτώνει......
Locally-advanced non-small cell lung cancer: shall immunotherapy be a new chance?
Locally advanced non-small cell lung cancer (NSCLC) represents approximately one third of presentations at diagnosis. Most patients are judged non-surgical due to disease extension, and chemo-radiotherapy still represents the standard therapeutic option, with unsatisfactory results in terms of overa...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Thorac Dis |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
AME Publishing Company
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5994493/ https://ncbi.nlm.nih.gov/pubmed/29951297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.12.53 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|